[1]
|
Vikhert, A.M. and Iua, S. (1964) The Juxtaglomerular Apparatus and Renin-Angiotensinase System (Endocrine Function of the Kidney). Arkhiv Patologii, 26, 3-17.
|
[2]
|
Forster, R.P. (1965) Kidney, Water, and Electrolytes. Annual Review of Physiology, 27, 183-232.
https://doi.org/10.1146/annurev.ph.27.030165.001151
|
[3]
|
Klemens, C.A. and Staruschenko, A. (2020) American Journal of Physiology-Renal Physiology Collections: Hypertension. American Journal of Physiology-Renal Physiology, 319, F1001-F1002.
https://doi.org/10.1152/ajprenal.00572.2020
|
[4]
|
Bahadoram, S., Davoodi, M., Hassanzadeh, S., et al. (2022) Renal Cell Carcinoma: An Overview of the Epidemiology, Diagnosis, and Treatment. Giornale Italiano di Nefrologia, 39, 2022-vol3.
|
[5]
|
Adeghate, E., Schattner, P. and Dunn, E. (2006) An Update on the Etiology and Epidemiology of Diabetes Mellitus. Annals of the New York Academy of Sciences, 1084, 1-29. https://doi.org/10.1196/annals.1372.029
|
[6]
|
Labochka, D., Moszczuk, B., Kukwa, W., et al. (2016) Mechanisms through Which Diabetes Mellitus Influences Renal Cell Carcinoma Development and Treatment: A Review of the Literature. Internation-al Journal of Molecular Medicine, 38, 1887-1894. https://doi.org/10.3892/ijmm.2016.2776
|
[7]
|
Ryu, T.Y., Park, J. and Scherer, P.E. (2014) Hyperglycemia as a Risk Factor for Cancer Progression. Diabetes & Metabolism Journal, 38, 330-336. https://doi.org/10.4093/dmj.2014.38.5.330
|
[8]
|
Habib, S.L. and Liang, S. (2014) Hyperactivation of Akt/mTOR and De-ficiency in Tuberin Increased the Oxidative DNA Damage in Kidney Cancer Patients with Diabetes. Oncotarget, 5, 2542-2550.
https://doi.org/10.18632/oncotarget.1833
|
[9]
|
Chitnis, M.M., Yuen, J.S., Protheroe, A.S., et al. (2008) The Type 1 Insu-lin-Like Growth Factor Receptor Pathway. Clinical Cancer Research, 14, 6364-6370. https://doi.org/10.1158/1078-0432.CCR-07-4879
|
[10]
|
Ouban, A., Muraca, P., Yeatman, T., et al. (2003) Expression and Distribution of Insulin-Like Growth Factor-1 Receptor in Human Carcinomas. Human Pathology, 34, 803-808. https://doi.org/10.1016/S0046-8177(03)00291-0
|
[11]
|
Aleksic, T., Chitnis, M.M., Perestenko, O.V., et al. (2010) Type 1 Insulin-Like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells. Cancer Research, 70, 6412-6419.
https://doi.org/10.1158/0008-5472.CAN-10-0052
|
[12]
|
Lkhagvadorj, S., Oh, S.S., Lee, M.R., et al. (2014) Insulin Recep-tor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis. Yonsei Medical Journal, 55, 861-870. https://doi.org/10.3349/ymj.2014.55.4.861
|
[13]
|
Rasmuson, T., Grankvist, K., Jacobsen, J., et al. (2004) Serum Insu-lin-Like Growth Factor-1 Is an Independent Predictor of Prognosis in Patients with Renal Cell Carcinoma. Acta Oncologica, 43, 744-748.
https://doi.org/10.1080/02841860410017260
|
[14]
|
Ostchega, Y., Fryar, C.D., Nwankwo, T., et al. (2020) Hypertension Prevalence among Adults Aged 18 and over: United States, 2017-2018. NCHS Data Brief, No. 364, 1-8.
|
[15]
|
Gray, R.E. and Harris, G.T. (2019) Renal Cell Carcinoma: Diagnosis and Management. American Family Physician, 99, 179-184.
|
[16]
|
Ishikane, S. and Takahashi-Yanaga, F. (2018) The Role of Angiotensin II in Cancer Metastasis: Potential of Renin-Angiotensin System Blockade as a Treatment for Cancer Metastasis. Biochemical Pharmacology, 151, 96-103.
https://doi.org/10.1016/j.bcp.2018.03.008
|
[17]
|
Macleod, L.C., Hotaling, J.M., Wright, J.L., et al. (2013) Risk Factors for Renal Cell Carcinoma in the VITAL Study. Journal of Urology, 190, 1657-1661. https://doi.org/10.1016/j.juro.2013.04.130
|
[18]
|
Makino, T., Izumi, K., Iwamoto, H., et al. (2020) The Impact of Hyperten-sion on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma. AntiCancer Research, 40, 4087-4093. https://doi.org/10.21873/anticanres.14407
|
[19]
|
Golden, A. (2021) Obesity’s Impact. Nursing Clinics of North America, 56, 13-14.
https://doi.org/10.1016/j.cnur.2021.08.004
|
[20]
|
Weikert, S. and Ljungberg, B. (2010) Contemporary Epidemiology of Renal Cell Carcinoma: Perspectives of Primary Prevention. World Journal of Urology, 28, 247-252. https://doi.org/10.1007/s00345-010-0555-1
|
[21]
|
Klinghoffer, Z., Yang, B., Kapoor, A., et al. (2009) Obesity and Renal Cell Carcinoma: Epidemiology, Underlying mechanisms and Management Considerations. Expert Review of Anticancer Therapy, 9, 975-987.
https://doi.org/10.1586/era.09.51
|
[22]
|
Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., et al. (2007) Low Adiponectin Levels Are Associated with Renal Cell Carcinoma: A Case-Control Study. International Journal of Cancer, 120, 1573-1578.
https://doi.org/10.1002/ijc.22526
|
[23]
|
Calle, E.E., Rodriguez, C., Walker-Thurmond, K., et al. (2003) Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. The New England Journal of Medicine, 348, 1625-1638.
https://doi.org/10.1056/NEJMoa021423
|
[24]
|
Soleimani, F., Dobaradaran, S., De-la-Torre, G.E., et al. (2022) Content of Toxic Components of Cigarette, Cigarette Smoke vs Cigarette Butts: A Comprehensive Systematic Review. Science of the Total Environment, 813, Article ID: 152667. https://doi.org/10.1016/j.scitotenv.2021.152667
|
[25]
|
Roger, V.L., Go, A.S., Lloyd-Jones, D.M., et al. (2011) Heart Disease and Stroke Statistics—2011 Update: A Report from the American Heart Asso-ciation. Circulation, 123, e18-e209.
|
[26]
|
Clague, J., Shao, L., Lin, J., et al. (2009) Sensitivity to NNKOAc Is Associated with Renal Cancer Risk. Carcinogenesis, 30, 706-710. https://doi.org/10.1093/carcin/bgp045
|
[27]
|
Huang, Y., Wang, Q., Tang, Y., et al. (2022) Identification and Validation of a Cigarette Smoke-Related Five-Gene Signature as a Prognostic Biomarker in Kidney Renal Clear Cell Carcinoma. Scientific Reports, 12, Article No. 2189.
https://doi.org/10.1038/s41598-022-06352-y
|
[28]
|
Hunt, J.D., van der Hel, O.L., McMillan, G.P., et al. (2005) Renal Cell Carcinoma in Relation to Cigarette Smoking: Meta-Analysis of 24 Studies. International Journal of Cancer, 114, 101-108. https://doi.org/10.1002/ijc.20618
|
[29]
|
Tsivian, M., Moreira, D.M., Caso, J.R., et al. (2011) Cigarette Smoking Is Associ-ated with Advanced Renal Cell Carcinoma. Journal of Clinical Oncology, 29, 2027-2031. https://doi.org/10.1200/JCO.2010.30.9484
|
[30]
|
Wiwanitkit, V. (2011) Renal Cell Carcinoma and Hepatitis C Virus Infec-tion: Is There Any Cause-Outcome Relationship. Journal of Cancer Research and Therapeutics, 7, 226-227. https://doi.org/10.4103/0973-1482.82931
|
[31]
|
Gordon, S.C., Moonka, D., Brown, K.A., et al. (2010) Risk for Renal Cell Carcinoma in Chronic Hepatitis C Infection. Cancer Epidemiology, Biomarkers & Prevention, 19, 1066-1073. https://doi.org/10.1158/1055-9965.EPI-09-1275
|
[32]
|
Washio, M., Mori, M., Mikami, K., et al. (2014) Risk Factors for Renal Cell Carcinoma in a Japanese Population. The Asian Pacific Journal of Cancer Prevention, 15, 9065-9070. https://doi.org/10.7314/APJCP.2014.15.21.9065
|
[33]
|
Ye, D., Eto, M., Chung, J.S., et al. (2014) Use of Targeted Thera-pies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement from China, Japan, Taiwan, Korea, and Australia. Clinical Genitourinary Cancer, 12, 225-233. https://doi.org/10.1016/j.clgc.2014.01.007
|
[34]
|
Znaor, A., Lortet-Tieulent, J., Laversanne, M., et al. (2015) International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality. European Urology, 67, 519-530. https://doi.org/10.1016/j.eururo.2014.10.002
|
[35]
|
Agnihotri, S., Kumar, J., Jain, M., et al. (2014) Renal Cell Carcinoma in India Demonstrates Early Age of Onset & a Late Stage of Presentation. Indian Journal of Medical Research, 140, 624-629.
|
[36]
|
Marumo, K., Satomi, Y., Miyao, N., et al. (2001) The Prevalence of Renal Cell Carcinoma: A Nation-Wide Survey in Japan in 1997. International Journal of Urology, 8, 359-365. https://doi.org/10.1046/j.1442-2042.2001.00314.x
|
[37]
|
Lin, J., Kamamia, C., Shriver, C.D., et al. (2019) Race and Renal Cell Carcinoma Stage at Diagnosis: An Analysis of the Surveillance, Epidemiology, and End Results Data. European Journal of Cancer Prevention, 28, 350-354.
https://doi.org/10.1097/CEJ.0000000000000484
|
[38]
|
Chow, W.H., Shuch, B., Linehan, W.M., et al. (2013) Racial Dis-parity in Renal Cell Carcinoma Patient Survival According to Demographic and Clinical Characteristics. Cancer, 119, 388-394. https://doi.org/10.1002/cncr.27690
|
[39]
|
Dobyns, A.C., Coutelle, N.A., Suthumphong, C.Y., et al. (2022) Race/Ethnicity and Advanced Stage of Renal Cell Carcinoma in Adults: Results from Surveillance, Epidemiology, and End Results Program 2007-2015. European Journal of Cancer Prevention, 31, 172-177.
|
[40]
|
Wong, E., Breau, R.H., Mallick, R., et al. (2019) Renal Cell Carcinoma in the Canadian Indigenous Population. Current Oncology, 26, e367-e371. https://doi.org/10.3747/co.26.4707
|
[41]
|
Fane, M. and Weeraratna, A.T. (2020) How the Ageing Microenvironment Influ-ences Tumour Progression. Nature Reviews Cancer, 20, 89-106. https://doi.org/10.1038/s41568-019-0222-9
|
[42]
|
Feng, X., Zhang, L., Tu, W., et al. (2019) Frequency, Incidence and Survival Outcomes of Clear Cell Renal Cell Carcinoma in the United States from 1973 to 2014: A SEER-Based Analysis. Medicine (Baltimore), 98, e16684.
https://doi.org/10.1097/MD.0000000000016684
|
[43]
|
Syed, J.S., Nguyen, K.A., Wu, C.Q., et al. (2017) Distinguishing Pediatric and Adolescent Renal Cell Carcinoma from Other Renal Malignancies. Pediatric Blood & Cancer, 64, e26315. https://doi.org/10.1002/pbc.26315
|
[44]
|
Verhoest, G., Veillard, D., Guillé, F., et al. (2007) Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma. European Urology, 51, 1298-1304. https://doi.org/10.1016/j.eururo.2006.11.056
|
[45]
|
Lughezzani, G., Paciotti, M., Fasulo, V., et al. (2019) Gender-Specific Risk Factors for Renal Cell Carcinoma: A Systematic Review. Current Opinion in Urology, 29, 272-278. https://doi.org/10.1097/MOU.0000000000000603
|
[46]
|
Pierorazio, P.M., Patel, H.D., Johnson, M.H., et al. (2016) Dis-tinguishing Malignant and Benign Renal Masses with Composite Models and Nomograms: A Systematic Review and Me-ta-Analysis of Clinically Localized Renal Masses Suspicious for Malignancy. Cancer, 122, 3267-3276. https://doi.org/10.1002/cncr.30268
|
[47]
|
Dy, G.W., Gore, J.L., Forouzanfar, M.H., et al. (2017) Global Burden of Uro-logic Cancers, 1990-2013. European Urology, 71, 437-446. https://doi.org/10.1016/j.eururo.2016.10.008
|
[48]
|
Aron, M., Nguyen, M.M., Stein, R.J., et al. (2008) Impact of Gender in Renal Cell Carcinoma: An Analysis of the SEER Database. Euro-pean Urology, 54, 133-140. https://doi.org/10.1016/j.eururo.2007.12.001
|
[49]
|
Newsholme, A. (1903) The Possible As-sociation of the Consumption of Alcohol with Excessive Mortality from Cancer. British Medical Journal, 2, 1529-1531. https://doi.org/10.1136/bmj.2.2241.1529
|
[50]
|
Nelson, D.E., Jarman, D.W., Rehm, J., et al. (2013) Alcohol-Attributable Cancer Deaths and Years of Potential Life Lost in the United States. American Journal of Public Health, 103, 641-648.
https://doi.org/10.2105/AJPH.2012.301199
|
[51]
|
Klein, W., Jacobsen, P.B. and Helzlsouer, K.J. (2020) Alcohol and Can-cer Risk: Clinical and Research Implications. JAMA, 323, 23-24. https://doi.org/10.1001/jama.2019.19133
|
[52]
|
Song, D.Y., Song, S., Song, Y., et al. (2012) Alcohol Intake and Renal Cell Cancer Risk: A Meta-Analysis. British Journal of Cancer, 106, 1881-1890. https://doi.org/10.1038/bjc.2012.136
|
[53]
|
Lee, J.E., Hunter, D.J., Spiegelman, D., et al. (2007) Alcohol Intake and Renal Cell Cancer in a Pooled Analysis of 12 Prospective Studies. JNCI: Journal of the National Cancer Institute, 99, 801-810. https://doi.org/10.1093/jnci/djk181
|
[54]
|
Bagnardi, V., Rota, M., Botteri, E., et al. (2015) Alcohol Consumption and Site-Specific Cancer Risk: A Comprehensive Dose-Response Meta-Analysis. British Journal of Cancer, 112, 580-593. https://doi.org/10.1038/bjc.2014.579
|
[55]
|
Moore, L.E., Boffetta, P., Karami, S., et al. (2010) Occupational Trichloroeth-ylene Exposure and Renal Carcinoma Risk: Evidence of Genetic Susceptibility by Reductive Metabolism Gene Variants. Cancer Research, 70, 6527-6536.
https://doi.org/10.1158/0008-5472.CAN-09-4167
|
[56]
|
Desimone, M.C., Rathmell, W.K. and Threadgill, D.W. (2013) Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response. JNCI: Journal of the National Cancer Institute, 105, 1355-1364. https://doi.org/10.1093/jnci/djt226
|
[57]
|
Abdul, K.S., Jayasinghe, S.S., Chandana, E.P., et al. (2015) Arsenic and Human Health Effects: A Review. Environmental Toxicology and Pharmacology, 40, 828-846. https://doi.org/10.1016/j.etap.2015.09.016
|
[58]
|
Song, J.K., Luo, H., et al. (2015) Association between Cadmium Exposure and Renal Cancer Risk: A Meta-Analysis of Observational Studies. Scientific Reports, 5, Article No. 17976. https://doi.org/10.1038/srep17976
|
[59]
|
Lee, J.E., Hunter, D.J., Spiegelman, D., et al. (2007) Intakes of Coffee, Tea, Milk, Soda and Juice and Renal Cell Cancer in a Pooled Analysis of 13 Prospective Studies. International Journal of Cancer, 121, 2246-2253.
https://doi.org/10.1002/ijc.22909
|
[60]
|
Scott, C.S. and Chiu, W.A. (2006) Trichloroethylene Cancer Epidemiology: A Con-sideration of Select Issues. Environmental Health Perspectives, 114, 1471-1478. https://doi.org/10.1289/ehp.8949
|
[61]
|
Kelsh, M.A., Alexander, D.D., Mink, P.J., et al. (2010) Occupational Trichloroeth-ylene Exposure and Kidney Cancer: A Meta-Analysis. Epidemiology, 21, 95-102. https://doi.org/10.1097/EDE.0b013e3181c30e92
|
[62]
|
Chiu, W.A., Caldwell, J.C., Keshava, N., et al. (2006) Key Scien-tific Issues in the Health Risk Assessment of Trichloroethylene. Environmental Health Perspectives, 114, 1445-1449. https://doi.org/10.1289/ehp.8690
|
[63]
|
Caldwell, J.C., Keshava, N. and Evans, M.V. (2008) Difficulty of Mode of Action Determination for Trichloroethylene: An Example of Complex Interactions of Metabolites and Other Chemical Exposures. En-vironmental and Molecular Mutagenesis, 49, 142-154. https://doi.org/10.1002/em.20350
|